Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
SMS Pharmaceuticals's operating assets for the quarter that ended in Jun. 2026 was ₹0 Mil. SMS Pharmaceuticals's operating liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil. SMS Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2026 was ₹13,624 Mil. Therefore, SMS Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2026 was 0.00.
SMS Pharmaceuticals Scaled Net Operating Assets Related Terms
SMS Pharmaceuticals Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for SMS Pharmaceuticals's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMS Pharmaceuticals Scaled Net Operating Assets Chart
NSE:SMSPHARMA vs LLY, JNJ, ABBV: Scaled Net Operating Assets Comparison
For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMS Pharmaceuticals Scaled Net Operating Assets vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where SMS Pharmaceuticals's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.00 mean?
SMS Pharmaceuticals (NSE:SMSPHARMA) has a Scaled Net Operating Assets of 0.00 as of Jun. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on SMS Pharmaceuticals and its competitors.
Is SMS Pharmaceuticals' Scaled Net Operating Assets too high?
SMS Pharmaceuticals' current Scaled Net Operating Assets is 0.00. Overall, SMS Pharmaceuticals has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SMS Pharmaceuticals' Scaled Net Operating Assets compare to LLY and JNJ?
SMS Pharmaceuticals' Scaled Net Operating Assets of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Drug Manufacturers company?
A good Scaled Net Operating Assets depends on the Drug Manufacturers industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on SMS Pharmaceuticals and its competitors. SMS Pharmaceuticals's current Scaled Net Operating Assets is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SMS Pharmaceuticals (NSE:SMSPHARMA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹278.49, compared to a current price of ₹363.50 — trading 30.5% above its estimated fair value. The current Scaled Net Operating Assets is 0.00. SMS Pharmaceuticals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For SMS Pharmaceuticals (NSE:SMSPHARMA), the current Scaled Net Operating Assets is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMS Pharmaceuticals (NSE:SMSPHARMA) Overvalued in 2026?
Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹363.50 is trading 30.5% above its estimated GF Value™ of ₹278.49.
GuruFocus considers SMS Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:SMSPHARMA:
Scaled Net Operating Assets: 0.00
GF Value™: ₹278.49 vs. price of ₹363.50 (30.5% above fair value)
No single metric tells the full story. See the NSE:SMSPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
78GF Score
Get the complete analysis for NSE:SMSPHARMA
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SMSPHARMA has been successfully added to your 
